HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James V Alvarez Selected Research

James V Alvarez Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 11/2004
11Breast Neoplasms (Breast Cancer)
01/2022 - 09/2006
3Residual Neoplasm
10/2020 - 07/2013
3Carcinogenesis
11/2006 - 11/2004
2Lung Neoplasms (Lung Cancer)
03/2006 - 11/2005
1Glioma (Gliomas)
01/2007
1Neoplasm Metastasis (Metastasis)
11/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2006
1Adenocarcinoma of Lung
11/2005

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2020 - 11/2004
3Phosphotransferases (Kinase)IBA
01/2020 - 11/2005
3Transcription Factors (Transcription Factor)IBA
01/2020 - 11/2004
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2007 - 06/2005
2CollagenIBA
01/2021 - 01/2019
2Pharmaceutical PreparationsIBA
10/2020 - 11/2005
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2019 - 12/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 12/2014
2CytokinesIBA
01/2019 - 07/2014
2Gefitinib (Iressa)FDA Link
03/2006 - 11/2005
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2006 - 11/2005
2ErbB Receptors (EGF Receptor)IBA
03/2006 - 11/2005
1AntigensIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1CytidineIBA
01/2022
1Discoidin Domain Receptor 2IBA
01/2021
1erastinIBA
01/2021
1Histone MethyltransferasesIBA
11/2020
1AntioxidantsIBA
01/2020
1Cystine (L-Cystine)IBA
01/2020
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2019
1tetramethyl rhodamine ethyl esterIBA
01/2019
1EnzymesIBA
12/2014
1Cadherins (E-Cadherin)IBA
11/2006
1Bortezomib (Velcade)FDA Link
09/2006
1DeoxyuridineIBA
09/2006
1CyclinsIBA
09/2006
1Cyclin D1IBA
09/2006
1Proteasome InhibitorsIBA
09/2006
1STAT Transcription FactorsIBA
05/2006
1Tyrosine (L-Tyrosine)FDA Link
03/2006
1Serine (L-Serine)FDA Link
03/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2005
1Epidermal Growth Factor (EGF)IBA
11/2005
1Complement System Proteins (Complement)IBA
06/2005

Therapy/Procedure

6Therapeutics
01/2022 - 11/2006
1Immunotherapy
01/2022
1Drug Therapy (Chemotherapy)
10/2018
1Neoadjuvant Therapy
07/2013